Dr. Antonio P. Strafella is the Krembil-Rossy chair in molecular imaging of neurodegenerative diseases and professor in the department of medicine (division of neurology) at the Toronto Western Hospital, University Health Network (UHN), University of Toronto (UofT). He is a movement disorder neurologist in the Edmond J. Safra Program in Parkinson’s Disease and Morton & Gloria Shulman Movement Disorders Clinic at the Toronto Western Hospital, UHN.
Dr. Strafella is the chair of research for the division of neurology at the UofT and a senior scientist at the Krembil Brain Institute (KBI) at UHN, and the Brain Health Imaging Centre at the Centre for Addiction and Mental Health (CAMH). He is a faculty member of the Institute of Medical Science (IMS) at UofT.
On the national front, Dr. Strafella is a fellow of the Canadian Academy of Health Sciences (CAHS) and currently serves on its governance and finance board. He also serves on the advisory board of the CIHR-Institute of Neuroscience, Mental Health and Addiction (INMHA), and the board of directors at Parkinson Canada.
Internationally, Dr. Strafella is the chair of the Neuroimaging Task Force endorsed by the International Parkinson and Movement Disorder Society (MDS). He is involved in several other commitments with the MDS, World Federation of Neurology, and over the years, has been invited to participate in panels for various funding agencies.
The focus of his research is on Parkinson’s and atypical parkinsonism using advanced neuroimaging technology and novel PET radio-ligands. He is using several PET tracers and novel radio-ligands combined with MRI techniques to investigate the pathophysiology of motor, cognitive, and behavioural symptoms in Parkinson’s and atypical parkinsonisms.